Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0004343 | HP:0004343 | Abnormal glycosphingolipid metabolism | 0 | ARSA CL E G H | 410 | 713 | ORPHA:309271 | Metachromatic leukodystrophy, adult form | HP:0040282 - Frequent | | | 253 | | |
HP:0004343 | HP:0004343 | Abnormal glycosphingolipid metabolism | 0 | ARSA CL E G H | 410 | 713 | ORPHA:309263 | Metachromatic leukodystrophy, juvenile form | HP:0040282 - Frequent | | | 253 | | |
HP:0004343 | HP:0004343 | Abnormal glycosphingolipid metabolism | 0 | GLA CL E G H | 2717 | 4296 | OMIM:301500 | Fabry disease | | | | 291 | | |
HP:0004343 | HP:0004343 | Abnormal glycosphingolipid metabolism | 0 | GM2A CL E G H | 2760 | 4367 | OMIM:272750 | Gm2-Gangliosidosis, ab variant | | | | 69 | | |
HP:0004343 | HP:0004343 | Abnormal glycosphingolipid metabolism | 0 | HEXB CL E G H | 3074 | 4879 | OMIM:268800 | Sandhoff disease | . | | | 80 | | |
HP:0004343 | HP:0004343 | Abnormal glycosphingolipid metabolism | 0 | MCOLN1 CL E G H | 57192 | 13356 | OMIM:252650 | Mucolipidosis IV | | | | 78 | | |
HP:0004343 | HP:0004343 | Abnormal glycosphingolipid metabolism | 0 | MCOLN1 CL E G H | 57192 | 13356 | ORPHA:578 | Mucolipidosis type IV | | | | 78 | | |
HP:0004343 | HP:0004343 | Abnormal glycosphingolipid metabolism | 0 | PSAP CL E G H | 5660 | 9498 | OMIM:611721 | Combined saposin deficiency | . | | | 81 | | |
HP:0004343 | HP:0004343 | Abnormal glycosphingolipid metabolism | 0 | PSAP CL E G H | 5660 | 9498 | ORPHA:309271 | Metachromatic leukodystrophy, adult form | HP:0040282 - Frequent | | | 81 | | |
HP:0004343 | HP:0004343 | Abnormal glycosphingolipid metabolism | 0 | PSAP CL E G H | 5660 | 9498 | ORPHA:309263 | Metachromatic leukodystrophy, juvenile form | HP:0040282 - Frequent | | | 81 | | |
HP:0004343 | HP:0410368 | Increased globoside Gb3 level | 1 | CL E G H | | | | | | | | | | |
HP:0004343 | HP:0410366 | Increased globoside Gb4 level | 1 | CL E G H | | | | | | | | | | |
HP:0004343 | HP:0004344 | Abnormality of cerebrosidase metabolism | 1 | CL E G H | | | | | | | | | | |
HP:0004343 | HP:0410370 | Absence of ganglioside GM3 | 1 | CL E G H | | | | | | | | | | |
HP:0004343 | HP:0033595 | Elevated circulating globotriaosylceramide concentration | 1 | GLA CL E G H | 2717 | 4296 | OMIM:301500 | Fabry disease | | | | 291 | | |
HP:0004343 | HP:0004345 | Ganglioside accumulation | 1 | GM2A CL E G H | 2760 | 4367 | OMIM:272750 | Gm2-Gangliosidosis, ab variant | | | | 69 | | |
HP:0004343 | HP:0004345 | Ganglioside accumulation | 1 | MCOLN1 CL E G H | 57192 | 13356 | OMIM:252650 | Mucolipidosis IV | . | | | 78 | | |
HP:0004343 | HP:0004345 | Ganglioside accumulation | 1 | MCOLN1 CL E G H | 57192 | 13356 | ORPHA:578 | Mucolipidosis type IV | HP:0040281 - Very frequent | | | 78 | | |
HP:0004343 | HP:0020160 | GM1-ganglioside accumulation | 2 | CL E G H | | | | | | | | | | |
HP:0004343 | HP:0003495 | GM2-ganglioside accumulation | 2 | GM2A CL E G H | 2760 | 4367 | OMIM:272750 | Gm2-Gangliosidosis, ab variant | . | | | 69 | | |